We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
CAVERJECT IMPULS alprostadil 20mcg powder and solvent for solution for injection, dual chamber cartridge in single use syringe device (Germany)
Section 19A approved medicine
CAVERJECT IMPULS alprostadil 20mcg powder and solvent for solution for injection, dual chamber cartridge in single use syringe device (Germany)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Medicines in short supply/unavailable
CAVERJECT IMPULSE alprostadil 20microgram powder for injection with 0.5mL diluent dual chamber cartridge in single use syringe device - ARTG 90197
Indication(s)
Intracavernosal alprostadil (PGE1) is indicated for the treatment of erectile dysfunction in adult males.
Intracavernosal alprostadil may be a useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.
Images
